SCHEMBL5873293

SCHEMBL5873293

CC(C)(C)c1ccc(-c2[c]c(C(F)(F)F)cc(-c3ccc(C(C)(C)C)cc3)c2)cc1

nearest known ligand 0.39

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 10/20 0.39
SCN5A Q14524 1/20 0.37
PDPK1 O15530 2/20 0.35
AKR1C2 P52895 1/20 0.34
AKR1C1 Q04828 1/20 0.34
RXRA P19793 2/20 0.33
RXRB P28702 2/20 0.33
RXRG P48443 2/20 0.33
CA12 O43570 1/20 0.33
CA9 Q16790 1/20 0.33
XDH P47989 1/20 0.33
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5873304 0.77 KIF11 (0.44) KIF11AKR1C2AKR1C1RXRARXRB
SCHEMBL5873300 0.76 AKR1C2 (0.42) KIF11AKR1C2AKR1C1RXRARXRB
SCHEMBL14075750 0.72 RXRA (0.53) KIF11SCN5ARXRARXRBRXRG
SCHEMBL13761760 0.71 KIF11 (0.62) KIF11SCN5ATSHR
SCHEMBL23319641 0.71 KIF11 (0.61) KIF11AKR1C2AKR1C1RXRARXRB
SCHEMBL4322427 0.71 KIF11 (0.61) KIF11AKR1C2AKR1C1RXRARXRB
SCHEMBL5134086 0.69 KIF11 (0.48) KIF11AKR1C2AKR1C1RXRARXRB
SCHEMBL26915 0.68 KIF11 (0.70) KIF11XDHTSHR
SCHEMBL3423876 0.68 KIF11 (0.70) KIF11XDHTSHR
SCHEMBL27957925 0.68 KIF11 (0.44) KIF11AKR1C2AKR1C1RXRARXRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7056996-B2 Productivity catalysts and microstructure control E. I. DU PONT DE NEMOURS AND COMPANY (US) 2006-06-06 US disclosed
US-20040127658-A1 Productivity catalysts and microstructure control EASTMAN CHEMICAL COMPANY 2004-07-01 US disclosed
US-20040077809-A1 Productivity catalysts and microstructure control EASTMAN CHEMICAL COMPANY 2004-04-22 US disclosed
EP-1404723-A2 OLEFIN POLYMERIZATION PROCESSES USING SUPPORTED CATALYSTS EASTMAN CHEMICAL COMPANY (US) 2004-04-07 EP disclosed
EP-1351997-A2 IMPROVED PRODUCTIVITY CATALYSTS AND MICROSTRUCTURE CONTROL EASTMAN CHEMICAL COMPANY (US) 2003-10-15 EP disclosed
US-6605677-B2 Group 8-10 transition metal based supported catalyst where the support is treated with a pore-filling agent; improved the catalyst productivity in the presence of hydrogen EASTMAN CHEMICAL COMPANY 2003-08-12 US disclosed
US-20020091210-A1 Olefin polymerization processes using supported catalysts E. I. DU PONT DE NEMOURS AND COMPANY 2002-07-11 US disclosed
US-20020065192-A1 Productivity catalysts and microstructure control MACKENZIE PETER BORDEN (US) 2002-05-30 US disclosed
WO-2002036641-A2 IMPROVED PRODUCTIVITY CATALYSTS AND MICROSTRUCTURE CONTROL EASTMAN CHEMICAL COMPANY (US) 2002-05-10 WO disclosed
WO-2002036642-A2 OLEFIN POLYMERIZATION PROCESSES USING SUPPORTED CATALYSTS EASTMAN CHEMICAL COMPANY (US) 2002-05-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040077809-A1 Productivity catalysts and microstructure control MYB, ST3GAL3, FASN KIF11 357/4885SCN5A 4702/4885PDPK1 1741/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.